To determine adipocytokines that play a regulatory role during obesity development, we explored the genes that encode growth factors and investigated the physiological functions for adipose tissue development. Here, we isolated amphiregulin (Areg) gene whose expression was significantly up-regulated in obese adipose tissues. Areg mRNA level was positively correlated with macrophage marker gene expression in adipose tissues in vivo. Unexpectedly, Areg transgenic mice showed less adipose tissue mass with increased mRNA expression levels of Tnf-α and peroxisome proliferator-activated receptor γ coactivator 1α (Pgc-1α) and delayed white adipose tissue development during the convalescent stage in a dextran sodium sulfate-induced colitis model. This study showed that Areg mRNA expression was significantly upregulated in obese adipose tissues and over-expression of Areg in white adipose tissue caused less adipose tissue mass.
| INTRODUCTION
Obesity with excess visceral adiposity and obesity-related metabolic disorders has been considered as a crucial health issue worldwide. These metabolic disorders are together termed as metabolic syndrome and increase the risk of development of type 2 diabetes, cardiovascular disease and cancers (Ouchi, Parker, Lugus, & Walsh, 2011; Spiegelman & Flier, 2001; Van Gaal, Mertens, & De Block, 2006) . Overnutrition, excess food intake and a sedentary lifestyle contribute to the aberrant accumulation of white adipose tissue through adipocyte hyperplasia and hypertrophy and lead to adipose pathological conditions (Ouchi et al., 2011; Spiegelman & Flier, 2001; Van Gaal et al., 2006) . Currently, adipose tissue is considered as a highly active endocrine and immune organ because white adipose tissue can produce over 20 hormones and signaling molecules termed as adipocytokines, which exert their biological effects through autocrine and paracrine signaling or peripherally through endocrine signaling (Halaas et al., 1995; Sell, Habich, & Eckel, 2012; Sun, Kusminski, & Scherer, 2011) . In particular, the physiological roles of adipocytokines in endocrine signaling have been discussed after the ob gene product cloned as leptin in 1994 was shown to be a master hormone that regulates sensations of hunger and satiety. To date, numerous in vivo studies have indicated that adipocytokines affect physiological processes concerning glucose and lipid metabolisms, energy homeostasis, reproduction and immune system (Sell et al., 2012; Sun et al., 2011) . Among these hormones from white adipose tissue, tumor necrosis factor-α (TNF-α) exerts well-described effects on glucose and lipid homeostasis during acute inflammation and has also been established as an important adipocytokine that is involved in the development of insulin resistance (Hotamisligil, Arner, Caro, Atkinson, & Spiegelman, 1995; Hotamisligil, Shargill, & Spiegelman, 1993) . Increased TNF-α production in obese adipose tissue is implicated in a variety of human diseases, including type 2 diabetes mellitus and cardiovascular diseases (Hotamisligil et al., 1993 (Hotamisligil et al., , 1995 .
Currently, mechanistic relationships between adipocytokines and cellular growth have been discussed from the viewpoints of adipocyte hyperplasia during obesity development and cancer cell proliferation. In a high-fat diet-fed mouse obese model, expansion of white adipose tissue is assumed to occur partially through increases in adipocyte number (Foster & Bartness, 2006) . In addition, Spalding et al. (2008) demonstrated that approximately 10% of the adipocytes are replaced annually at all adult ages regardless of the body mass index, indicating that adipocyte proliferation is involved in determining the fat mass in humans. However, the underlying relationship between adipocyte number and the pathogenesis of obesity, including abnormal expression of adipocytokines, remains unclear. However, several studies have shown that prevalence and mortality rate of certain types of cancers such as breast and colon cancers are associated with increased body fat and have, hence, inspired further research on the involvement of adipocytokines in a mechanistic link between obesity and cancers. Previous in vitro studies on cancer cell lines have demonstrated that certain adipocytokines can promote tumor growth and cancer cell proliferation through receptor-mediated signaling (Engin, 2017; Font-Burgada, Sun, & Karin, 2016) . Moreover, several clinical studies have examined the pathological roles of adipocytokines in distinct tumor types to show the relationship between adipocytokines and cancer incidence and prognosis (Engin, 2017; Font-Burgada et al., 2016) . These observations inspired us to further consider that unidentified adipocytokines may have pathological functions that intervene between obesity and diseases related to aberrant cell proliferation such as cancers.
Because we have recently performed a comparative analysis of gene expression in obese adipose tissues of db/db mice (Sanada et al., 2013 (Sanada et al., , 2016 , we expected that these transcriptome data would be useful to isolate candidate genes related to aberrant cell proliferation. In this study, we isolated amphiregulin (Areg), which is highly expressed in obese white adipose tissue. AREG is a well-studied member of the epidermal growth factor (EGF) family and plays a key role in cell survival, proliferation and motility during a variety of physiological and pathological processes (Busser, Sancey, Brambilla, Coll, & Hurbin, 2011) . However, because the functional relationship between the EGF family and obesity development has been little elucidated, we established transgenic mice specifically over-expressing AREG in white adipose tissue and aimed to examine the basic roles of AREG in white adipose tissue. Next, we expected AREG secreted from white adipose tissues has roles as a novel adipocytokine in an endocrine signaling. In particular, because AREG has been supposed to promote epithelial repair and mucosal healing following acute epithelial injury during dextran sulfate sodium (DSS)-induced experimental colitis (Brandl et al., 2010; Hsu et al., 2010) , we built a hypothesis that increased AREG in serum of the transgenic mice can modulate the tissue repair process after the DSS treatment. In this study, we showed that over-expression of Areg in white adipose tissue did not modulate DSS-induced colon inflammation but significantly decreased white adipose mass during the recovery from experimental colitis.
| RESULTS

| Areg is highly expressed in mouse obese adipose tissues
In our previous reports, we isolated total RNAs from db/db and db/+ epididymal adipose tissues and compared the gene expression profiles by DNA microarray data analysis (Sanada et al., 2013 (Sanada et al., , 2016 . Data analysis indicated that 1810 transcript levels were significantly up-regulated in the adipose tissue of db/db mice (p < .05). Of these 1,810 genes, we searched genes encoding growth factors which expression was upregulated (ratio >3, p < .05) in adipose tissue of db/db mice and found increased mRNA expression levels of Areg, fibroblast growth factor 13 (Fgf13) and fibroblast growth factor 21 (Fgf21). To confirm the differential expression of these genes, total RNA from individual mice in the two groups was subjected to quantitative PCR. In particular, we showed that Areg mRNA expression in the epididymal adipose tissue of db/db mice was significantly up-regulated by more than 80-fold compared to that of db/+ mice ( Figure 1a ). In addition, we also performed quantitative RT-PCR analysis to determine the expression level of Areg in epididymal adipose tissue of mice with diet-induced obesity. In mice fed with a high-fat diet (HFD) for 16 weeks, Areg mRNA level in white adipose tissue was significantly up-regulated (10-fold) compared to that in age-matched nonobese control mice (Figure 1b ). An increased number of macrophage in adipose tissue is an important event for fat inflammation and systemic metabolic disorders because increased macrophage infiltration into adipose tissue is associated with adipose inflammation and insulin resistance. To determine whether Areg mRNA level in obese adipose tissue correlated with macrophage infiltration, we measured mRNA expression of Areg, Fgf13 and Fgf21, and macrophage marker genes such as Emr1 and Msr1 in epididymal white adipose tissue of individual HFD-fed mice. There was a significant correlation between Areg and Emr1 and Msr1 mRNA levels (p < .01), as demonstrated using Pearson's correlation coefficient analysis (Figure 1c 
| Transgenic mice specifically overexpressing AREG in white adipose tissues have less fat tissue mass
Previous reports showed that Fgf13 and Fgf21 mRNA expression in white adipose tissue of obese mice was significantly up-regulated compared to that of control mice (Mejhert et al., 2010; Zhang et al., 2008) . In particular, adipose-derived FGF21 increased expression of Ucp1 and other thermogenic genes in fat tissues in an autocrine and a paracrine manner (Chau, Gao, Yang, Wu, & Gromada, 2010; Fisher et al., 2012) . However, because the potential role of AREG in white adipose tissues remains unclear, we established transgenic mice specifically over-expressing AREG in white adipose tissues and focused on adipose mass and metabolic regulation. Here, we used the enhancer-promoter region of adipocyte fatty acid-binding protein (aP2) gene to control the expression of mouse Areg transgene in white adipose tissues ( Figure 2a ). We obtained an independent line of transgenic mice, and Areg transgene expression was evaluated by quantitative PCR with RNA isolated from the epididymal adipose tissue of AREG Tg mice and age-matched control mice at 10 weeks of age. We observed that AREG mRNA expression in the epididymal adipose tissue of AREG Tg mice was significantly up-regulated compared to that of wildtype (WT) mice (Figure 2b ). In addition, Areg transgene expression was further evaluated with RNAs isolated from several tissues of AREG Tg mice and age-matched control mice at 5 weeks of age. Areg mRNA over-expression was observed only in the white adipose tissue ( Figure S2a ), indicating that the use of the aP2 promoter resulted in high expression levels of the transgene in adipose tissues. We further confirmed Areg mRNA expression in mature adipocytes isolated from epididymal adipose tissue of AREG Tg mice ( Figure S2b ), suggesting that the mature adipocytes were responsible for Areg mRNA overexpression. To examine whether AREG protein is actually produced in white adipose tissue, serum concentration of AREG was analyzed. Compared to the WT mice, over-expression of Areg in white adipose tissue significantly leaded to an increase in serum AREG concentration (159 pg/ml) ( Figure 2c ). Body weight, food intake and gain in body and liver weights did not differ between the two groups. Moreover, blood metabolite (glucose, triglyceride and total cholesterol) levels were not significantly different between AREG Tg and WT mice (Table S1) . We further performed glucose tolerance test and found no difference in blood glucose level between AREG Tg and WT mice ( Figure S3 ). Taken together, there was no difference in the glucose metabolism between AREG Tg and WT mice. However, contrary to the expectation, the epididymal adipose tissue of AREG Tg mice was smaller in size than that of WT mice (Figure 2d ). To better visualize the morphology of the adipose cells, transverse sections of epididymal adipose tissue of AREG Tg and WT mice were stained with hematoxylin and eosin ( Figure S4 ). We found smaller adipocytes in AREG Tg mice compared to those in WT mice (Figure 2e ), which was consistent with lower leptin mRNA expression in adipose tissue of AREG Tg mice (Figure 2f ). Because we unexpectedly found that the Areg expression down-regulated adipose tissue mass, we examined the effect of AREG over-expression on obesity development in db/db mice. AREG Tg mice were mated with db/+ mice to generate db/db, AREG Tg mice. Body weight and the adipose tissues of db/db, AREG Tg mice were smaller in size than those of control db/db mice (Figure 3a-c) , suggesting the Areg expression negatively regulated white adipose development in genetically obese db/db mice. However, EGF family has been supposed to be involved in repair responses after DSS administration via a promoted epithelial cell proliferation (Brandl et al., 2010; Hsu et al., 2010) . In this study, we observed an increased AREG level in serum from AREG Tg mice and AREG receptor (ErbB1 and ErbB2) mRNA expression in mouse colon (data not shown), suggesting a possibility that AREG enhances the epithelial cell proliferation. Here, we firstly hypothesized that increased AREG level in serum promotes the tissue repair process after the DSS treatment. However, there was no difference in disease activity index, colon length and mRNA levels of IL-6 and TNF-α in the colons between AREG Tg and WT mice (data not shown), suggesting that AREG produced in adipose tissues did not affect DSS-induced colon inflammation. However, it is well known that severe diseases such as cancers and serious inflammatory diseases lead to the reduction in body weight accompanied with decreased fat mass in a state of poor nutrition. In this study, we further examined adipose growth during the recovery from DSS-induced colitis to show the possibility of AREG as a negative regulator for adipose development.
As shown in Figures 4a-d and S5, AREG Tg mice showed continued weight loss compared to that in WT mice and contained only <40% of the mass of white adipose tissue of the WT mice. To determine the changes in gene expression in AREG Tg mice, we performed DNA microarray analysis using RNA samples from the epididymal adipose tissue of 12-week-old AREG Tg mice with age-matched WT mice (Table 1) . Previous reports have shown that mRNA expression levels of early growth response 1 and 2 (Egr1 and Egr2) respond to EGF stimulation (Eckstein et al., 2008) , whereas, in this study, mRNA expression levels of Egr1 and Egr2 were actually up-regulated in white adipose tissues of AREG Tg mice. Furthermore, the expression levels of several genes linked to triglyceride synthesis were down-regulated in white adipose tissues of AREG Tg mice. We found that mRNA expression levels of TNF-α and peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) were up-regulated in AREG Tg mice. We also performed quantitative PCR analysis to determine the expression level of Tnfα and Pgc-1α genes in white adipose tissue of transgenic and WT mice and confirmed that their expression levels increased in AREG Tg mice compared to those in age-matched WT mice both under the normal condition (Figure 5a and b) and during a recovery from DSS-induced colitis ( Figure S6 ).
| DISCUSSION
In this study, we focused on Areg, which is highly expressed in obese white adipose tissue. Because the potential role of AREG in white adipose tissue remains unclear, we here created transgenic mice over-expressing AREG in white adipose tissue to show its roles as a novel adipocytokine. However, AREG has been supposed to promote epithelial cell proliferation following acute epithelial injury during DSS-induced experimental colitis (Brandl et al., 2010; Hsu et al., 2010) . Thus, in the latter half of this study, we built a hypothesis that increased AREG in serum of the transgenic mice can modulate the tissue repair process after the DSS treatment and further focused on the role of AREG for adipose growth during the recovery from the severe disease. Unexpectedly, the transgenic mice showed reduced white adipose tissue mass and consistently smaller crosssectional adipocytes. These negative effects of AREG were observed in both normal and genetically obese mice. In addition, AREG expression suppressed adipose growth during recovery from DSS-induced colitis without affecting colon inflammation. Limited information is available on the role of EGF family in adipose tissue development and functions. Genes to Cells
Previous in vitro studies have demonstrated that EGF suppresses the differentiation of rat primary adipocyte precursor cells and mouse 3T3-L1 cells (Li et al., 2008; Serrero, 1987) . In addition, the exposure of stromal cells from human white adipose tissue to EGF decreased both the number of developing fat cells and activity of glycerol-3-phosphate dehydrogenase, a marker of adipose differentiation in a dose-and time-dependent manner (Hauner, Rohrig, & Petruschke, 1995) . Ai et al. (2017) recently showed that EGF promoted the proliferation of adipose stem cells possibly through the signal transducer and activator of transcription (STAT) signal pathway. Taken together, these observations suggested that AREG produced in white adipose tissues negatively regulated adipocyte differentiation partially via an enhanced precursor cells proliferation in vivo. However, the current study showed that Pgc-1α expression was significantly up-regulated in white adipose tissue of AREG Tg mice. PGC-1α is considered as a master regulator of mitochondrial biogenesis and energy expenditure and acts as a cold-inducible protein that controls adaptive thermogenesis in brown adipose tissue (Herzig et al., 2001; Russell, Foletta, Snow, & Wadley, 2014) . Fasting and physical exercise induce PGC-1α expression in several tissues, including liver and skeletal muscle, thereby increasing gluconeogenesis and mitochondrial biogenesis. These suggested that the enhanced energy expenditure was involved in negative regulation of adipose tissue weight by AREG; however, because mitochondrial uncoupling protein 1 (Ucp1) mRNA expression was not significantly different between AREG Tg and WT (Fruhbeck, Mendez-Gimenez, Fernandez-Formoso, Fernandez, & Rodriguez, 2014; Pao et al., 2004) . Taken together, there is a possibility that AREG produced in adipose tissues down-regulates adipose tissue mass through enhanced energy expenditure or lipolysis. Although the pathological roles of AREG during obesity development remain unclear, increased AREG expression could be recognized as one of the compensatory regulations against aberrant accumulation of white adipose tissue. Moreover, to date, the oncogenic activity of AREG has been focused in most common epithelial malignancies, such as lung, breast, colorectal, ovary and prostate carcinomas, as well as in some hematological and mesenchymal cancers (Addison et al., 2010; Bostwick, Qian, & Maihle, 2004; Ciardiello et al., 1991) . Because AREG is further involved in resistance to chemotherapy for several cancer treatments (Addison et al., 2010; Bostwick et al., 2004; Ciardiello et al., 1991) , it has been afforded as a potential therapeutic target and as a biomarker for predicting cancer outcomes or treatment efficacy. The current study provides a potential insight in the pathological relationship between obesity development and morbidity rates of drug-resistant cancers. Total RNAs from individual mice (n = 3) were prepared from epididymal adipose tissues of 12-week-old AREG Tg mice and age-matched WT mice. DNA microarray analysis was repeated with the Cy3 and Cy5 dyes reversed (a dye swap). Fold change represents the average of mRNA expression level in AREG Tg mice relative to WT mice. 4 | EXPERIMENTAL PROCEDURES 4.1 | Animals C57BL/6 mice (Charles River Japan) were housed in a room with controlled temperature (24°C) and a 12-hr light/dark cycle. The mice were maintained according to the Guide for the Care and Use of Laboratory Animals established by Hiroshima University (C16-16) . The pcDNA3.1(+)-aP2 carrying the 6-kilobase (kb) aP2 promoter and a polyadenylation signal encoded by bovine growth hormone was provided by Dr Y. Kamei (Kyoto Prefectural University, Kyoto, Japan) (Kamei et al., 2010) . The complete cDNA of mouse AREG was generated by PCR amplification with mouse intestine cDNA. The pcDNA3.1(+)-aP2-AREG vector was constructed by ligating the AREG cDNA at the XhoI site of pcDNA3.1(+)-aP2. The transgene was used for microinjection into C57BL/6 mouse eggs. The male chimeras harboring the AREG transgene were mated with C57BL/6 female mice to obtain F1 offspring. The heterozygous F1 male offspring from this breeding were then backcrossed with purebred C57BL/6J females to obtain F2 offspring; this process was continued until the F3 generation of mice was isolated. The male heterozygous AREG transgenic mice (AREG Tg mice) and their littermate WT mice were killed at 10-15 weeks of age. Seven-week-old male C57BL/6 mice were fed AIN93G (normal diet, ND) or HFD for 16 weeks. db/db (BKS.Cgm+/+ Lepr db/J, 6 weeks old) and db/+ (BKS.Cg-Dock7m +/+ Lepr db/J, 6 weeks old) mice were obtained from Charles River Japan. Female db/+ mice were mated with male AREG Tg mice to generate db/+, AREG Tg mice. Matings were then performed with db/+, AREG Tg mice in the same group to produce db/db, AREG Tg mice and db/db mice.
| Isolation of mature adipocytes
Epididymal white adipose tissue isolated from male db/db mice was minced in phosphate-buffered saline and digested with 1 mg/ml collagenase type I (Worthington Chemical Corporation) for 30 min at 37°C. The cell suspension was filtered through a 100-μm filter and centrifuged at 233× g for 1 min to separate mature adipocytes from SVF.
| PCR analyses
Quantitative PCR analyses were performed on total RNAs prepared with an RNeasy lipid tissue kit (Qiagen Sciences, Germantown, MD). The reverse transcriptase reaction was carried out with 1 μg total RNA as a template to synthesize cDNA using ReverTra Ace (TOYOBO, Osaka, Japan) and random hexamers (TOYOBO), according to the manufacturer instructions. cDNA and primers were added to the THUNDERBIRD SYBR qPCR Mix (TOYOBO), Tnfα ** *
| Blood analysis
Serum was obtained by centrifugation of the whole blood sample at 900× g for 10 min at 4°C and stored at −20°C for late use. Serum AREG was measured by mouse amphiregulin ELISA Kit (ab100668; Abcam, Cambridge, MA) according to the manufacturer instructions.
| Induction of DSS colitis
Colitis was induced in 7-to 8-week-old sex-matched WT and AREG Tg mice by addition of DSS (MP Biomedicals, Solon, OH) to the drinking water at 2% (wt/vol) for 7 days. For recovery experiments, the DSS solution was replaced with water on day 7 and mice continued to drink regular water for a further 3 days. Body weight was monitored daily in addition to the disease activity index.
| DNA microarray analysis
DNA microarray analysis was performed in accordance with our previous study (Sanada et al., 2013 (Sanada et al., , 2016 . Total RNA derived from epididymal fat of AREG and control mice at 8 weeks of age was isolated using RNeasy Lipid Tissue Mini Kit and subjected to cRNA synthesis for a DNA microarray analysis according to the manufacturer's instructions (whole mouse genome 60-mer oligo microarray, Agilent Technologies, Santa Clara, CA). Gene expression data were obtained with Agilent Feature Extraction software according to the Agilent protocol to fit the direct labeling procedure. Files and images, including error values and p values, were exported from Agilent Feature Extraction software (version 9.5). The microarray data are also deposited in the NCBI GEO database (available on the World Wide Web at www.ncbi.nlm.nih.gov/geo) under accession number GSE103875.
| Histopathology
To measure diameter of cross-sectional adipocytes, samples of epididymal fat of AREG and control mice at 8 weeks of age were fixed in neutral-buffered 10% formalin, and processed by staining paraffin-embedded transverse sections (10 μm) with hematoxylin and eosin (H&E).
| Statistical analysis
To determine significant differences in body weight, tissue weight and mRNA expression level between AREG Tg mice and age-matched WT mice, the two-tailed unpaired t-test was carried out. p-Values of <.05 (two-sided) were considered statistically significant.
